Registry to assess pregnancy outcomes in Mali
Official title: Assessment of Pregnancy Outcomes Through Demographic Surveillance and Prospective Data Collection at a Health Facility in Kalifabougou, Mali
Run by National Institute of Allergy and Infectious Diseases (NIAID) · NCT06468319 · Data updated 2026-11-12
This study is collecting information about pregnancy and baby health in Mali to help test new treatments for preventing malaria during pregnancy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 15 Years to 49 Years |
| Sex | Women only |
| Enrollment | 9500 (estimated) |
| Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) NIH |
| Locations | 1 site (Kalifabougou, Koulikoro) |
| Status | Recruiting |
| Started | August 5, 2024 |
| Main results expected | June 2030 |
| Study ends | June 2030 |
| Registry record updated | March 13, 2026 |
| Trial ID | NCT06468319 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include females aged 15 to 49 who are either pregnant or of childbearing potential residing in the Kalifabougou area.
✕Probably not a fit
Patients who are temporarily residing in the study area or have conditions that may jeopardize their safety or rights may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This registry collects data on pregnancy rates and outcomes, as well as infant health, at a health facility in Kalifabougou, Mali. It involves two cohorts: the Community Census Cohort, which follows women of child-bearing age for up to three years to detect pregnancies, and the Health Facility Cohort, which gathers prospective data from pregnant women attending antenatal care. The aim is to inform future clinical trials testing monoclonal antibodies to prevent malaria in pregnancy by systematically collecting information on pregnancy events, complications, and outcomes.
Why it matters
Potential benefit: If successful, this registry could improve understanding of pregnancy outcomes and inform interventions to prevent malaria in pregnant women.
How similar studies have gone: Other studies have shown success in using registries to collect data on pregnancy outcomes, making this approach promising.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Community Census Cohort: 1. Females of childbearing potential or pregnant females. 2. Aged 15 to 49 years. 3. Able to provide verbal individual informed consent. Health Facility Cohort: 1. Pregnant females 15 to 49 years and their subsequent offspring. 2. Resides in or in the health catchment area of Kalifabougou and willing to return to the health center for Antenatal Care (ANC) visits. 3. Able to provide written individual informed consent for herself and her future offspring(s). Exclusion Criteria: Community Census Cohort: 1. Temporary residence in the study area. 2. Other condition(s) that, in the opinion of the investigator, would jeopardize the safety or rights of an individual participating in the study, interfere with the evaluation of the study objectives, or render the participant unable to comply with the protocol. Health Facility Cohort: 1. Temporary residence in the study area. 2. Other condition(s) that, in the opinion of the investigator, would jeopardize the safety or rights of an individual participating in the study, interfere with the evaluation of the study objectives, or render the participant unable to comply with the protocol.
Where it's running
-
Kalifabougou MRTC Clinic
Kalifabougou, Koulikoro, Mali Recruiting
Study contacts
- Principal investigator: Kassoum Kayentao, MD, MPH, PhD — Faculté de Médecine Pharmacie d'Odontostomatologie (FMOS)
- Study coordinator: Kassoum Kayentao, MD, MPH, PhD
- Email: kayentao@icermali.org
- Phone: +223 7646 0173
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lotilaner safety and blood activity in healthy adults in Mali
This Phase 1b study tests if a single dose of lotilaner is safe, tolerable, and shows mosquito-killing activity in healthy adults living in Mali.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
See if the R21/Matrix-M malaria vaccine works in real-world settings for kids under 5
This study tests how well the R21/Matrix-M vaccine protects children under 5 in Burkina Faso and Uganda when used in typical clinical care.
-
Interprofessional Training to Improve Care for Peri-Delivery Patients with Substance Use Disorder
This program tests INSPIRE, a set of online and in-person trainings for healthcare teams to reduce stigma and improve care for people with substance use disorder around labor, delivery, and postpartum at the University of Utah.
-
Lower-extremity blood pressure monitoring during cesarean under spinal anesthesia
This study tests whether noninvasive blood pressure monitoring from the toe is better than the arm at predicting neonatal outcomes during cesarean delivery with spinal anesthesia.
-
Care4mommies: a compassion-based approach to support moms-to-be
A compassion-based program with pregnancy-specific content is being tested to see if it helps pregnant people build self-compassion and strengthen the bond with their baby.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.